EUVIMEDEUVIMED entdecken
Crossref

Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration

Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta

Phytomedicine · 2025-11 · 148 · 157448

DOI: 10.1016/j.phymed.2025.157448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Zuber Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy (Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab…. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Neuroprotective Agents, Demyelinating Diseases, Isoleucine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Multiple Sclerosis (MS) is a chronic autoimmune neurodegenerative condition causing demyelination and axonal damage. Ethidium bromide (EBrD) induces focal demyelination by damaging glial cells, especially oligodendrocytes and astrocytes. 4-hydroxyisoleucine (4-HI) exhibits neuroprotective potential by regulating key signaling pathways. To our knowledge, this is the first study assessing the neuroprotective potential of 4-HI in an experimental rat model of demyelination. OBJECTIVE: This study aims to evaluate the neuroprotective potential of 4-HI in an EBrD-induced experimental rat model of demyelination. METHODS: Adult Wistar rats received EBrD injection into the intracerebropeduncle region (ICP) to induce demyelination. Animals were administered 4-HI orally at a dose of 100 or 200 mg/kg and semaglutide at 2 mg/kg. Neurobehavioral performance, pro-inflammatory cytokines, apoptotic markers, neurotransmitter levels, and hematological indices were assessed. Histopathological analysis was conducted to evaluate myelin damage, neuroinflammation, and myelin repair. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to examine IGF-1 and GLP-1 signaling. Further, molecular docking studies were performed to predict 4-HI interactions with IGF-1R and GLP-1R. RESULTS: The study found that 4-HI treatment improved neuromuscular coordination, locomotion, and cognitive function. It reduced pro-inflammatory cytokines, pro-apoptotic markers, and restored neurotransmitter imbalances. Histopathological analysis revealed enhanced myelin repair, reduced neuroinflammation, normalized hematological profiles, and mitigated pathological alterations in various brain regions. Additionally, qRT-PCR showed that 4-HI administration modulated mRNA expression of IGF-1, GLP-1, and cytokines. CONCLUSION: 4-HI exhibits neuroprotective potential in the EBrD-induced demyelination by targeting IGF-1 and GLP-1 pathways, reducing neuroinflammation, restoring myelin integrity, and improving neurobehavioral outcomes. Our findings suggest that 4-HI holds therapeutic potential in demyelination, though further validation is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor INeuroprotective AgentsDemyelinating DiseasesIsoleucineGlucagon-Like Peptide 1AnimalsRats, WistarRatsMaleDisease Models, AnimalMolecular Docking SimulationSignal Transduction

Stichwörter der Autor:innen

4-Hydroxyisoleucine (4-HI)DemyelinationIGF-1/GLP-1 SignalingMultiple sclerosis (MS)NeuroinflammationNeuroprotection

Substanzen

Insulin-Like Growth Factor INeuroprotective AgentsIsoleucineGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy (Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, 144603, India), Moga, Punjab, India; Research Scholar, IK Gujral Pun…
  • Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy (Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, 144603, India), Moga, Punjab, India. Electronic address: sidharthmeh…
  • Department of Pharmaceutics, ISF College of Pharmacy (Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, 144603, India), Moga, Punjab, India.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Science and Engineering Research Board

Zitieren

APA

Khan, Z., Mehan, S., & Gupta, G. D. (2025). Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration. Phytomedicine, 148, 157448. https://doi.org/10.1016/j.phymed.2025.157448

Vancouver

Khan Z, Mehan S, Gupta GD. Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration. Phytomedicine. 2025;148:157448. doi:10.1016/j.phymed.2025.157448

BibTeX
@article{Khan2025,
  author = {Khan, Zuber and Mehan, Sidharth and Gupta, Ghanshyam Das},
  title = {Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration},
  journal = {Phytomedicine},
  year = {2025},
  volume = {148},
  pages = {157448},
  doi = {10.1016/j.phymed.2025.157448}
}
Kostenlos starten →